FDA approves nasal spray as the first needle-free option for anaphylaxis. BNC News


August 12, 2024 Tags:

The Food and Drug Administration (FDA) has recently approved a groundbreaking nasal spray called Neffy, marking a significant advancement in the treatment of severe allergic reactions. This new spray, developed by ARS Pharmaceuticals, is the first needle-free emergency treatment for potentially life-threatening allergies, offering a much-needed alternative to traditional epinephrine auto-injectors like EpiPen.
Neffy is designed to treat anaphylaxis, a severe allergic reaction that can involve multiple body systems and require immediate medical attention. Anaphylaxis can be life-threatening, and it’s estimated to cause up to 200 deaths annually. This new nasal spray provides a simpler and potentially less intimidating option for managing such emergencies.

The nasal spray is intended for both adults and children who weigh at least 66 pounds. It delivers a single dose of epinephrine, the same crucial medication used in autoinjectors, but without the need for a needle. The Asthma and Allergy Foundation of America (AAFA) has welcomed this development, noting that it may help overcome some of the barriers associated with using epinephrine. For instance, children and others who fear needles might find Neffy to be a more user-friendly alternative.

Neffy’s approval comes after a series of studies involving 175 healthy adults, which measured how effectively the nasal spray delivered epinephrine compared to traditional injection methods. Although the FDA initially declined to approve the spray last year, requesting additional testing, it has now given the green light following positive recommendations from independent experts.

Richard Lowenthal, co-founder and CEO of ARS Pharmaceuticals, explained that using Neffy is straightforward. The device requires no preparation before use—much like Narcan, the nasal spray used to reverse opioid overdoses. Users simply place the device into the nostril and press the plunger, which releases the medication. The epinephrine is absorbed through the nasal mucosa, which is an advantage over traditional epinephrine delivered through a vial, as the nasal spray includes a special solvent that aids in the absorption of the medication.

While Neffy represents a major innovation in emergency allergy treatment, users should be aware of potential side effects. These include mild nasal discomfort, headaches, runny nose, nausea, moderate dizziness, vomiting, and mild throat irritation. Despite these possible effects, Neffy is expected to significantly improve access to emergency allergy treatment and provide a less daunting option for those managing severe allergies.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

You may also like

Kennedy’s HHS Overhaul Puts Addiction Treatment At Risk

A major shakeup in the U.S. Department of Health and Human Services (HHS) could lead to the weakening—or even elimination—of....

Deadly Fungal Superbug Candida Auris Spreads Rapidly in Hospitals

A dangerous fungal superbug, Candida auris (C. auris), is rapidly spreading in hospitals and nursing homes, raising serious public health....

Researchers in Limbo as Columbia Caves to Trump’s Demands for $400M

Columbia University is facing intense scrutiny after agreeing to strict policy changes to regain $400 million in federal funding revoked....

U.S. Cuts LGBTQ Health Research Funding, Sparking Outrage

The Trump administration has abruptly canceled dozens of federal grants supporting research on LGBTQ health, drawing criticism from scientists and....

Canada Expands Dental Care Plan Ahead of Expected Election

Millions of uninsured Canadians will soon have access to affordable dental care as the federal government expands its Canadian Dental....

Diffabilities YEG Fights Stigma On World Down Syndrome Day

An Edmonton-based organization, Diffabilities YEG, hosted a special event on Friday to mark World Down Syndrome Day. The event aimed....

Bella Ramsey Opens Up About Autism Diagnosis: "It Was Liberating"

Bella Ramsey, known for their Emmy-nominated role in The Last of Us, recently revealed their autism diagnosis. In an interview....

Measles Cases Double in Alberta as Vaccination Rates Decline

Measles, once considered eradicated in Canada, is making a troubling comeback in Alberta. The number of confirmed cases has nearly....

Slushy Drinks Could Make Kids Sick—Experts Warn!

Researchers have warned that children under the age of 8 should avoid slushy ice drinks containing glycerol. This comes after....

Alberta Government Lawyers Defend Youth Gender-Affirming Care Ban In Court

Alberta's controversial transgender law returned to court on Tuesday, with government lawyers defending it as a science-based measure designed to....

Utah Becomes First U.S. State to Ban Fluoride in Public Water

Utah is making history by becoming the first state to ban fluoride in public drinking water. Despite opposition from dentists....

Butter Lovers, Beware! New Study Links Butter Intake to Shorter Lifespan

Butter is a kitchen staple, loved for its creamy richness. But could your daily dollop be shortening your life? A....